Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders

Archives of Dermatology

Volumn 133, Issue 9, 1997, Pages 1081-1086

  Iwatsuki, Keiji ^a,b   Ohtsuka, Mikio ^a   Harada, Hiroshi ^a   Han, Gangwen ^a   Kaneko, Fumio ^a  

^a Fukushima Medical University   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN LYMPHOMA; VIRUS DETECTION; VIRUS INFECTION;

EID: 0030885830     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.9.1081     Document Type: Article

References (28)

1. Strauss SE, Cohen JI, Tosato G, Meier J. Epstein-Barr virus infections: biology, pathogenesis and management. Ann Intern Med. 1993;118:45-58.
2. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell. 1994; 77:791-793.
3. Rowe M, Lear AL, Cloom-Carter D, Davies AH, Rickinson AB. Three passways of Epstein-Barr virus gene activation from EBNA 1-positive latency in B lymphocytes. J Virol. 1992;66:122-131.
4. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 1989;84:51-55.
5. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol. 1994;145:239-252.
6. Jones JF, Shurim S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N Engl J Med. 1988;318:733-741.
7. Harabuchi Y. Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer. 1996;77:2137-2149.
8. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 1991; 337:320-322.
9. Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood. 1991;77:799-808.
10. Su IJ, Tsai TF, Cheng AL, Chen CC. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma. J Am Acad Dermatol. 1993;29:685-692.
11. Asada H, Okada N, Tei H, et al. Epstein-Barr virus-associated large granular lymphocyte leukemia with cutaneous infiltration. J Am Acad Dermatol. 1994;31: 241-255.
12. Harada H, Iwatsuki K, Kaneko F. Detection of Epstein-Barr virus genes in malignant lymphoma with clinical and histologic features of cytophagic histiocytic panniculitis. J Am Acad Dermatol. 1994;31:379-383.
13. Cho KH, Kim CW, Lee DY, Sohn SJ, Kim DW, Chung JH. Epstein-Barr virusassociated lymphoproliferative lesion of the skin presenting recurrent necrotic papulovesicles of the face. Br J Dermatal. 1996;134:791-796.
14. Nishioka K, Murata M, Ishikawa T. A case of cytophagic histiocytic panniculitis of 14 years' duration and associated with T cell lymphoma at autopsy: special reference to cellular infiltrates in the initial lesion with those in the autopsy. Nishinihon J Dermatol. 1996;58:44-49.
15. Ikeya T, Nitta Y, Suzuki T, et al. A case of T-cell lymphoma in a child with unusual clinical course showing hydroa vacciniforme-like eruptions, repeated unknown fevers and arthralgia and abnormal liver functions. Jpn J Dermatol. 1991; 101:1423-1431.
16. Tabata N, Aiba S, Ichinohazama R, et al. Hydroa vacciniforme-like lymphomatoid papulosis in a Japanese child: a new subset. J Am Acad Dermatol. 1995; 32:378-381.
17. Terashi H, Katagiri K, Fujiwara S, Shinkai H, Ichikawa H, Takayashu S. Association of recurrent ulcerating papules resembling lymphomatoid papulosis with hydroa vacciniforme. Nishinihon J Dermatol. 1988;52:75-79.
18. Kato M, Sugiyama S, Jimbow K. Lymphomatoid papulosis: clinical course and morphological characteristics of inflammatory cells in a case occurring at childhood. Jpn J Dermatol. 1977;87:647-656.
19. Ando I, Okitsu H, Kukita A, Kishino S, Mizoguchi K. A case of hemophagocytic syndrome associated with B-cell lymphoma. J Eur Acad Dermatol Venereol. 1995; 4:77-81.
20. Igarashi H, Ogai M, Ogawa H. An autopsy case of malignant histiocytosis associated with mosquito hypersensitivity. Jpn J Clin Dermatol. 1992;46:817-821.
21. Winkelmann RK, Walter BEJ. Hemorrhagic diathesis associated with benign histiocytic, cytophagic panniculitis and systemic histiocytosis. Arch Intern Med. 1980; 140:1460-1463.
22. Harris N, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
23. Ruiz-Maldonado R, Parrilla FM, Orozco-Covarrubias ML, Ridaura C, Sanchez LT, McKinster CD. Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol. 1995;32:37-44.
24. Hidano A, Kawakami M, Yago A. Hypersensitivity to mosquito bite and malignant histiocytosis. Jpn J Exp Med. 1982;52:303-306.
25. Osato T, Mizuno F, Imai S, et al. African Burkitt's lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia tirucalli. Lancet. 1987;1:1257-1258.
26. Teramoto N, Sarker AB, Tonoyama Y, et al. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies. Cancer. 1996;77: 2339-2347.
27. Anagnostopoulos I, Hummel M, Kaudewitz P, Korbjuhn P, Leoncini L, Stein H. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations. Br J Dermatol. 1996;134:276-281.
28. Monterroso V, Bujan W, Jaramillo O, Medeiros LJ. Subcutaneous tissue involvement by T-cell lymphoma: a report of 2 cases. Arch Dermatol. 1996;132:1345-1350.